Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA, Solanky BS, De Angelis F, Parker RA, Weir CJ, Stutters J, Carrasco FP, Schneider T, Doshi A, Calvi A, Williams T, Plantone D, Monteverdi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: solanky bs. J Magn Reson Imaging. 2024 Jun;59(6):2192-2201. doi: 10.1002/jmri.29017. Epub 2023 Oct 3. J Magn Reson Imaging. 2024. PMID: 37787109 Clinical Trial.
Challenges and Perspectives of Quantitative Functional Sodium Imaging (fNaI).
Gandini Wheeler-Kingshott CAM, Riemer F, Palesi F, Ricciardi A, Castellazzi G, Golay X, Prados F, Solanky B, D'Angelo EU. Gandini Wheeler-Kingshott CAM, et al. Front Neurosci. 2018 Nov 9;12:810. doi: 10.3389/fnins.2018.00810. eCollection 2018. Front Neurosci. 2018. PMID: 30473659 Free PMC article.
Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.
Brownlee WJ, Solanky B, Prados F, Yiannakas M, Da Mota P, Riemer F, Cardoso MJ, Ourselin S, Golay X, Gandini Wheeler-Kingshott C, Ciccarelli O. Brownlee WJ, et al. J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):755-760. doi: 10.1136/jnnp-2018-319634. Epub 2019 Apr 4. J Neurol Neurosurg Psychiatry. 2019. PMID: 30948625 Free PMC article.
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT.
De Angelis F, Connick P, Parker RA, Plantone D, Doshi A, John N, Stutters J, MacManus D, Prados F, Marshall I, Solanky B, Samson RS, Barkhof F, Ourselin S, Braisher M, Ross M, Cranswick G, Pavitt SH, Gnanapavan S, Giovannoni G, Wheeler-Kingshott CAMG, Hawkins C, Sharrack B, Bastow R, Weir CJ, Stallard N, Chandran S, Chataway J. De Angelis F, et al. Southampton (UK): NIHR Journals Library; 2020 May. Southampton (UK): NIHR Journals Library; 2020 May. PMID: 32453521 Free Books & Documents. Review.
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
Solanky BS, John NA, DeAngelis F, Stutters J, Prados F, Schneider T, Parker RA, Weir CJ, Monteverdi A, Plantone D, Doshi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS-SMART Investigators. Solanky BS, et al. AJNR Am J Neuroradiol. 2020 Dec;41(12):2209-2218. doi: 10.3174/ajnr.A6809. Epub 2020 Nov 5. AJNR Am J Neuroradiol. 2020. PMID: 33154071 Free PMC article. Clinical Trial.
A Risk Score for Predicting Multiple Sclerosis.
Dobson R, Ramagopalan S, Topping J, Smith P, Solanky B, Schmierer K, Chard D, Giovannoni G. Dobson R, et al. PLoS One. 2016 Nov 1;11(11):e0164992. doi: 10.1371/journal.pone.0164992. eCollection 2016. PLoS One. 2016. PMID: 27802296 Free PMC article.
Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial.
Arenas-Pinto A, Stöhr W, Jäger HR, Haddow L, Clarke A, Johnson M, Chen F, Winston A, Godi C, Thust S, Trombin R, Cairns J, Solanky BS, Golay X, Paton NI; PIVOT Neurocognitive sub-study Team. Arenas-Pinto A, et al. Among authors: solanky bs. Clin Infect Dis. 2016 Jul 15;63(2):257-64. doi: 10.1093/cid/ciw279. Epub 2016 May 3. Clin Infect Dis. 2016. PMID: 27143662 Free PMC article. Clinical Trial.
Patterns of inflammation, microstructural alterations, and sodium accumulation define multiple sclerosis subtypes after 15 years from onset.
Ricciardi A, Grussu F, Kanber B, Prados F, Yiannakas MC, Solanky BS, Riemer F, Golay X, Brownlee W, Ciccarelli O, Alexander DC, Gandini Wheeler-Kingshott CAM. Ricciardi A, et al. Among authors: solanky bs. Front Neuroinform. 2023 Mar 23;17:1060511. doi: 10.3389/fninf.2023.1060511. eCollection 2023. Front Neuroinform. 2023. PMID: 37035717 Free PMC article.
23 results